S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
NYSE:CO

Global Cord Blood - CO Stock Forecast, Price & News

$2.67
+0.08 (+3.09%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.55
$2.67
50-Day Range
$2.05
$3.49
52-Week Range
$2.03
$5.50
Volume
186,832 shs
Average Volume
166,788 shs
Market Capitalization
$324.54 million
P/E Ratio
4.17
Dividend Yield
N/A
Price Target
N/A
CO stock logo

About Global Cord Blood (NYSE:CO) Stock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Global Cord Blood in a report on Friday, June 3rd. They issued a "strong-buy" rating for the company.

Global Cord Blood Trading Up 1.2 %

Shares of Global Cord Blood stock traded up $0.03 during trading hours on Friday, reaching $2.62. 75 shares of the company's stock were exchanged, compared to its average volume of 121,939. The firm has a market capitalization of $318.46 million, a price-to-earnings ratio of 4.05 and a beta of 0.14. The company has a fifty day moving average of $2.80 and a 200-day moving average of $3.33. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50.

Global Cord Blood (NYSE:CO - Get Rating) last issued its earnings results on Tuesday, July 5th. The medical research company reported $0.14 earnings per share (EPS) for the quarter. Global Cord Blood had a net margin of 40.29% and a return on equity of 10.63%. The firm had revenue of $46.88 million for the quarter.

Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Stock News Headlines

Reviewing Global Cord Blood (NYSE:CO) & Marpai (NASDAQ:MRAI)
See More Headlines
Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Company Calendar

Last Earnings
7/05/2022
Today
8/12/2022
Next Earnings (Estimated)
8/29/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
1,260
Year Founded
N/A

Profitability

Net Income
$79.04 million
Pretax Margin
50.50%

Debt

Sales & Book Value

Annual Sales
$196.12 million
Cash Flow
$0.71 per share
Book Value
$6.34 per share

Miscellaneous

Free Float
N/A
Market Cap
$324.54 million
Optionable
Optionable
Beta
0.14

Key Executives

  • Ms. Ting Zheng (Age 50)
    CEO & CEO of Beijing Division
    Comp: $516.68k
  • Mr. Bing Chuen Chen (Age 46)
    Chief Financial Officer
    Comp: $516.68k
  • Ms. Xin Xu (Age 68)
    Chief Technology Officer
    Comp: $122.78k
  • Ms. Rui Arashiyama (Age 63)
    Chief Exec. Officer of Guangdong & Zhejiang Divisions
    Comp: $257.5k
  • Ms. Cathy Bai
    VP of Corp. Fin.













CO Stock - Frequently Asked Questions

How have CO shares performed in 2022?

Global Cord Blood's stock was trading at $4.19 on January 1st, 2022. Since then, CO shares have decreased by 36.3% and is now trading at $2.67.
View the best growth stocks for 2022 here
.

Are investors shorting Global Cord Blood?

Global Cord Blood saw a decline in short interest in July. As of July 31st, there was short interest totaling 197,600 shares, a decline of 13.0% from the July 15th total of 227,000 shares. Based on an average daily trading volume, of 170,600 shares, the days-to-cover ratio is presently 1.2 days. Approximately 0.6% of the shares of the stock are short sold.
View Global Cord Blood's Short Interest
.

When is Global Cord Blood's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 29th 2022.
View our CO earnings forecast
.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) released its earnings results on Tuesday, July, 5th. The medical research company reported $0.14 EPS for the quarter. The medical research company had revenue of $46.88 million for the quarter. Global Cord Blood had a net margin of 40.29% and a trailing twelve-month return on equity of 10.63%.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

Who are Global Cord Blood's major shareholders?

Global Cord Blood's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Group One Trading L.P. (0.00%).
View institutional ownership trends
.

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $2.67.

How much money does Global Cord Blood make?

Global Cord Blood (NYSE:CO) has a market capitalization of $324.54 million and generates $196.12 million in revenue each year. The medical research company earns $79.04 million in net income (profit) each year or $0.64 on an earnings per share basis.

How many employees does Global Cord Blood have?

The company employs 1,260 workers across the globe.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181.

This page (NYSE:CO) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.